Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark L Chapman

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of General Physiology|July 27, 2005
K channel subconductance levels result from heteromeric pore conformationsMark L Chapman, Antonius M J VanDongen
Molecular Pharmacology|September 3, 2016
The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 ChannelsJonathan W Theile, Matthew D Fuller, Mark L Chapman
Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology|March 6, 2007
The influence of crank configuration on muscle activity and torque production during arm crank ergometryPaul M Smith, Mark L Chapman, Kathryn E Hazlehurst, et al.
Pflugers Archiv : European Journal of Physiology|November 12, 2005
Allosteric effects of external K+ ions mediated by the aspartate of the GYGD signature sequence in the Kv2.1 K+ channelMark L Chapman, Marie L Blanke, Howard S Krovetz, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2024
Development and characterization of pyridyl carboxamides as potent and highly selective Na<sub>v</sub>1.8 inhibitorsMichael Poslusney, Glen Ernst, Yifang Huang, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2014
Recent progress in sodium channel modulators for painSharan K Bagal, Mark L Chapman, Brian E Marron, et al.
Anesthesia and Analgesia|July 18, 2009
The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neuronsXin Su, Neil A Castle, Brett Antonio, et al.
The American Journal of Gastroenterology|April 20, 2004
The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patientsDavid Norman Moskovitz, Carol Bodian, Mark L Chapman, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of the First Orally Available, Selective K<sub>Na</sub>1.1 Inhibitor: <i>In Vitro</i> and <i>In Vivo</i> Activity of an Oxadiazole SeriesAndrew M Griffin, Kristopher M Kahlig, Robert John Hatch, et al.
Neuropharmacology|June 23, 2010
A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in ratsXu-Feng Zhang, Char-Chang Shieh, Mark L Chapman, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of General Physiology|July 27, 2005
K channel subconductance levels result from heteromeric pore conformationsMark L Chapman, Antonius M J VanDongen
Molecular Pharmacology|September 3, 2016
The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 ChannelsJonathan W Theile, Matthew D Fuller, Mark L Chapman
Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology|March 6, 2007
The influence of crank configuration on muscle activity and torque production during arm crank ergometryPaul M Smith, Mark L Chapman, Kathryn E Hazlehurst, et al.
Pflugers Archiv : European Journal of Physiology|November 12, 2005
Allosteric effects of external K+ ions mediated by the aspartate of the GYGD signature sequence in the Kv2.1 K+ channelMark L Chapman, Marie L Blanke, Howard S Krovetz, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2024
Development and characterization of pyridyl carboxamides as potent and highly selective Na<sub>v</sub>1.8 inhibitorsMichael Poslusney, Glen Ernst, Yifang Huang, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2014
Recent progress in sodium channel modulators for painSharan K Bagal, Mark L Chapman, Brian E Marron, et al.
Anesthesia and Analgesia|July 18, 2009
The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neuronsXin Su, Neil A Castle, Brett Antonio, et al.
The American Journal of Gastroenterology|April 20, 2004
The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patientsDavid Norman Moskovitz, Carol Bodian, Mark L Chapman, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of the First Orally Available, Selective K<sub>Na</sub>1.1 Inhibitor: <i>In Vitro</i> and <i>In Vivo</i> Activity of an Oxadiazole SeriesAndrew M Griffin, Kristopher M Kahlig, Robert John Hatch, et al.
Neuropharmacology|June 23, 2010
A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in ratsXu-Feng Zhang, Char-Chang Shieh, Mark L Chapman, et al.
Pageof 2